Study S000962

Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes": a Randomized Open-label Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05305794
Acronym: TOLEDDO
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: RECRUITING
Enrollment: 76
Start: 2022-07-12
Primary completion: 2028-08
Lead sponsor: Centre Hospitalier Universitaire Dijon
Conditions: Double Diabetes
Interventions: DRUG:Insulin + semaglutide treatment; DRUG:Usual insulin treatment; BIOLOGICAL:Biological check-up
Results posted: FALSE

Registered primary outcomes

Percentage of time spent within glycemic target range (0.70-1.80 g/l) [Change from baseline at Day 180]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.